Skip to content
Joints & Immunity — Interleukin inhibitorsATC L04AC05

Ustekinumab

Prescription onlyWHO essential medicine

IL-12/23 antibody for psoriasis and inflammatory bowel disease.

Starts working
Weeks
Half-life
About 3 weeks
In use since
—
Pregnancy
Use with caution

Overview

Ustekinumab blocks the shared p40 unit of IL-12 and IL-23. It is injected every 8–12 weeks and is used for plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.

How it works

Blocks inflammation signals IL-12 and IL-23.

Ustekinumab belongs to the Interleukin inhibitors. How Interleukin inhibitors work: block one specific immune messenger that drives a particular disease.

Uses

  • Plaque psoriasis
  • Psoriatic arthritis
  • Crohn's disease
  • Ulcerative colitis

Available as: subcutaneous injection, iv infusion (induction).

Typical dose

Adults
45–90 mg subcutaneously at weeks 0 and 4 then every 12 weeks (psoriasis); IV induction in IBD.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Upper respiratory infections
  • Headache
  • Tiredness
  • Injection site redness

Serious — get medical help

Uncommon, but need prompt attention

  • Serious infections
  • Allergic reactions
  • Reversible leukoencephalopathy (rare)

Warnings

  • Screen for TB before starting

Who should avoid it

  • Active serious infection
  • Active TB

Interactions

  • Live vaccines — avoid
Check Ustekinumab against your own medicines

Using it safely

Alcohol
Usually no problem in moderation. No specific interaction.
Food and drink
Not applicable.
If you miss a dose
Inject when remembered, then continue as scheduled.
Stopping it
Only on advice of your specialist.
Driving
No effect.
Tests and checks
Infection symptoms; TB screening
If too much is taken
No specific antidote.
Storage
Refrigerate.
Legal status
United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HAustralia: Prescription only (Schedule 4)

Pregnancy and breastfeeding

Pregnancy

Use with caution

Limited data; may be continued when benefit outweighs risk.

Breastfeeding

Use with caution

Limited data.

Special groups

Kidney disease
No adjustment.
Liver disease
No adjustment.
Older adults
Higher infection risk.

Brand names

United States
Stelara, Wezlana
United Kingdom
Stelara, Wezenla
India
Stelara, Ustekinumab biosimilars
Australia
Stelara

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Do I need a prescription for Ustekinumab?

Yes — Ustekinumab is prescription-only in most countries.

Can I take Ustekinumab during pregnancy?

Use with caution. Limited data; may be continued when benefit outweighs risk. Always check with a doctor or midwife.

How quickly does Ustekinumab work?

Weeks.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.